(Q47248140)

12 January 2018

title

Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy (English)

1 reference

12 January 2018

1 reference

Ugur Deligezer

1

1 reference

12 January 2018

Yesim Eralp

2

1 reference

12 January 2018

Ebru E Akisik

3

1 reference

12 January 2018

Elif Z Akisik

4

1 reference

12 January 2018

Pinar Saip

5

1 reference

12 January 2018

Erkan Topuz

6

1 reference

12 January 2018

Nejat Dalay

7

1 reference

12 January 2018

publication date

1 January 2008

1 reference

12 January 2018

Clinical Chemistry and Laboratory Medicine

published in

1 reference

12 January 2018

volume

46

1 reference

12 January 2018

issue

3

1 reference

12 January 2018

page(s)

311-317

1 reference

12 January 2018

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulating nucleic acids and proteomics of plasma/serum: clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Overview of cell death signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Prediction of breast tumor progression by integrity of free circulating DNA in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Increased plasma DNA integrity index in head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Quantification of total plasma cell-free DNA in ovarian cancer using real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulating nucleic acids in plasma/serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Evaluation of cell death caused by CDF (cyclophosphamide, doxorubicin, 5-fluorouracil) multi-drug administration in the human breast cancer cell line MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulation DNA: biological implications for cancer metastasis and immunology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

Prospective Study of Quantitation of Plasma DNA Levels in the Diagnosis of Malignant versus Benign Prostate Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.080

21 January 2018

Identifiers

DOI

10.1515/CCLM.2008.080

1 reference

12 January 2018

1 reference

12 January 2018